Does Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative Clostridium difficile Infection? - Wikidata - thesis-toulmin - TriplyDB

Does Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative Clostridium difficile Infection?

Does Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative Clostridium difficile Infection?

http://www.wikidata.org/entity/Q33629080

about

Sleeping with the enemy: Clostridium difficile infection in the intensive care unit.Novel Antimicrobials for the Treatment of Clostridium difficile Infection.

P2860

Q42654359-8824B305-F051-4767-B5B2-7D158D26C5BC Q55405974-EE3B1E23-4609-4CD4-A0F4-845BA8E85408

P2860

Does Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative Clostridium difficile Infection?

http://www.wikidata.org/entity/Q33629080

description

2017 nî lūn-bûn

@nan

2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Does Adjunctive Tigecycline Im ...... ostridium difficile Infection?

@ast

Does Adjunctive Tigecycline Im ...... ostridium difficile Infection?

@en

type

label

Does Adjunctive Tigecycline Im ...... ostridium difficile Infection?

@ast

Does Adjunctive Tigecycline Im ...... ostridium difficile Infection?

@en

prefLabel

Does Adjunctive Tigecycline Im ...... ostridium difficile Infection?

@ast

Does Adjunctive Tigecycline Im ...... ostridium difficile Infection?

@en

P1433

Q33629080-BB5FCF5C-5785-4E00-B253-F66B4F60DC60

P1476

Q33629080-5280E986-AB29-4B67-B322-063681C9234C

P2093

Q33629080-15789E1D-9927-4570-975A-9743C533292E

Q33629080-1D201D63-70D2-45C5-871C-727E8C673F93

Q33629080-9E80FE29-6391-4729-841C-0093853F0BCE

Q33629080-A0273789-3618-4C66-BE65-EDC58AE6C879

Q33629080-BD38F84E-C260-44E7-BB7E-E304EF4F6220

Q33629080-DC3B6A27-5E05-4690-9FAE-F1B655AB10F3

P2860

Q33629080-0A5A4225-4B76-4CB9-8CB0-7E62F123030D

Q33629080-1B3FD47D-A599-404A-8B42-8A82987CDCE9

Q33629080-24DC0DDD-C615-474F-B9F6-8D6EC9892FF1

Q33629080-2CE605A6-8E10-4BAC-9686-33F25F4A98EA

Q33629080-2FA36850-263D-4605-8872-16F6B0EB9DE2

Q33629080-3017933A-4F46-48EF-9DFC-487E8D9D7AF7

Q33629080-38AE180A-6D70-48A7-A61D-8875FE0CC796

Q33629080-46026536-7067-427E-B6FA-AB7E05115ABE

Q33629080-56395ADF-422E-4663-8069-D5CA44D7AD24

Q33629080-66DCAA20-B0EB-4355-90B4-FFC893E320F6

P304

Q33629080-D11E3159-93D0-46B0-B45F-ED606790EB80

P31

Q33629080-1BEA9AC5-AF31-424E-8841-72ECB3FA9180

P356

Q33629080-87D74643-2D27-4D75-8DB3-713B6B352780

P433

Q33629080-55F9EFC7-7763-419A-B550-69BFD06E5FBA

P478

Q33629080-1F7A3C60-6F09-4D1B-A3C4-95CFB74AE98E

P50

Q33629080-5E19C667-3839-4CDB-9915-8A565E3F45BD

P577

Q33629080-658CED36-65A2-480A-99A9-2942209FB265

P698

Q33629080-5CA569CF-D51C-44CF-BA71-2274491BC795

P921

Q33629080-DE5A1B43-E95B-41A9-A02F-CAEC5881B43A

P932

Q33629080-30C92361-25E3-496C-91B7-011E3C9989F5

P356

P1433

Open forum infectious diseases

P1476

Does Adjunctive Tigecycline Im ...... ostridium difficile Infection?

@en

P2093

Carolyn D Alonso

http://www.w3.org/2001/XMLSchema#string

Graham M Snyder

http://www.w3.org/2001/XMLSchema#string

Howard S Gold

http://www.w3.org/2001/XMLSchema#string

Mary T LaSalvia

http://www.w3.org/2001/XMLSchema#string

Sharon B Wright

http://www.w3.org/2001/XMLSchema#string

Westyn Branch-Elliman

http://www.w3.org/2001/XMLSchema#string

P2860

Influence of tigecycline on expression of virulence factors in biofilm-associated cells of methicillin-resistant Staphylococcus aureus.

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates.

Beneficial effect of oral tigecycline treatment on Clostridium difficile infection in gnotobiotic piglets.

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.

Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile.

Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection

Effects of tigecycline and vancomycin administration on established Clostridium difficile infection.

A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity.

Clostridium difficile ribotype does not predict severe infection.

P304

ofw264

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/OFID/OFW264

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Monica V Mahoney

P577

2017-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28480257

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

5413996

http://www.w3.org/2001/XMLSchema#string